Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study of N-3 Fatty Acid on Plasma Triglyceride Levels in Hypertriglyceridemic HIV Patients Receiving Highly Active Antiretroviral Therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Sep 2023
Price :
$35
*
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- 16 Feb 2010 Trial sponsor and lead centre (GlaxoSmithKline) added as reported by ClinicalTrials.gov.
- 04 Jun 2009 New trial record.